Adient price target raised to $20 from $17.50 at BofA

BofA raised the firm’s price target on Adient (ADNT) to $20 from $17.50 and keeps an Underperform rating on the shares. The firm raised its target due to progress on costs and potential business gains from production shift into the U.S. post tariffs, the analyst tells investors in a note post Q2 and production estimate revisions.